NIH GUIDE, Volume 25, Number 42, December 6, 1996




P.T. 34


  Drugs/Drug Abuse 

  Treatment, Medical+ 


National Institute on Drug Abuse


The National Institute on Drug Abuse (NIDA) is soliciting proposals

from qualified organizations having in-house capability to perform

screening of in vitro transporter binding and uptake assays utilizing

cells transfected with human dopamine, serotonin and norepinephrine

transporters.  Proprietary test compounds will be evaluated in

established assays, and the resulting data will be utilized by the

Cocaine Treatment Discovery Program of the NIDA Medications

Development Division.  Offerors must indicate possession of current

DEA registration for Schedule II-V substances prior to award and have

applied for Schedule I registration at the time of award.  It is

anticipated that one cost reimbursement, completion type contract

will be awarded for a period of three years, with two options each

for an additional year, as well as additional quantity options.

Request for Proposals (RFP) No. N01DA-7-8071 will be available

electronically on or about December 4, 1996, and may be accessed

through the NIH Gopher and/or the Internet by using the following

electronic mail addresses and instruction:


1.  NIH Home Page (via the World Wide Web): Access the NIH Home Page

by using  Once you are at the NIH Home Page,

select "Grants and Contracts"; select NIH Gopher directory: listed

under the Contracts Page section.  Once at the NIH R&D Gopher, select

RFPs Available; select NIDA; and select RFP N01DA-7-8071.


2.  NIH Gopher: Point your Gopher client to GOPHER.NIH.GOV Port 70

(you should now be in the NIH Gopher).  Select Grant and Research

Information; select R&D Request for Proposals (RFP); select RFPs

Available; select NIDA; and, select RFP N01DA-7-8071.


Please note that the RFP for this acquisition is streamlined and

includes only the Work Statement, deliverable and reporting

requirements, special requirements and mandatory qualification, if

any, the Technical Evaluation Criteria, and proposal preparation

instructions.  All information required for the submission of an

offer will be contained in the electronic RFP package.  Following

proposal submission and the initial review process, offerors

comprising the competitive range will be requested to provide

additional documentation to the Contracting Officer.




Responses to this RFP will be due on January 21, 1997.  Any

responsible offeror may submit a proposal that will be considered by

the Government.  This advertisement does not commit the Government to

award a contract.  For further information contact:


Kenneth E. Goodling

Contracts Management Branch

National Institute on Drug Abuse

5600 Fishers Lane, Room 10-49

Rockville, MD  20857

Telephone:  (301) 443-6677

FAX:  (301) 443-7595




Return to 1996 Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.